We are live on ! Find out more
NGM

NGM Biopharmaceuticals, Inc. Common Stock

Delisted

NGM was delisted on the 4th of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
PS
1
Peter Svennilson
$214M +$14.7M +902,315 +5%
RCP
2
Rho Capital Partners
New York
$46.4M
BlackRock
3
BlackRock
New York
$27.8M -$927K -56,780 -2%
GA
4
Greenspring Associates
Maryland
$19.4M
ACM
5
Aquilo Capital Management
California
$12.9M +$17.1M +1,047,184 New
Point72 Asset Management
6
Point72 Asset Management
Connecticut
$12.3M +$16.3M +996,295 New
Royal Bank of Canada
7
Royal Bank of Canada
Ontario, Canada
$11.5M -$28K -1,716 -0.2%
Vanguard Group
8
Vanguard Group
Pennsylvania
$5.84M +$233K +14,298 +3%
State Street
9
State Street
Massachusetts
$5.66M +$1.34M +82,379 +22%
CS
10
Candriam SCA
Luxembourg
$4.37M
RSCM
11
Rock Springs Capital Management
Maryland
$4.33M
JRP
12
Jasper Ridge Partners
California
$3.81M +$28.6K +1,750 +0.6%
Northern Trust
13
Northern Trust
Illinois
$3.26M +$35.3K +2,163 +0.8%
BBA
14
Baker Bros. Advisors
New York
$3.08M
JP Morgan Chase
15
JP Morgan Chase
New York
$3M -$683K -41,823 -15%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$2.89M +$779K +47,697 +25%
Marshall Wace
17
Marshall Wace
United Kingdom
$2.82M +$3.73M +228,551 New
Citadel Advisors
18
Citadel Advisors
Florida
$2.53M +$2.73M +167,388 +446%
Renaissance Technologies
19
Renaissance Technologies
New York
$1.84M +$2.43M +149,100 New
Jacobs Levy Equity Management
20
Jacobs Levy Equity Management
New Jersey
$1.7M +$2.25M +137,964 New
Nuveen
21
Nuveen
North Carolina
$1.41M -$1.76M -108,031 -49%
Millennium Management
22
Millennium Management
New York
$1.17M +$435K +26,647 +39%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$1.01M +$385K +23,567 +40%
Charles Schwab
24
Charles Schwab
California
$996K +$27K +1,655 +2%
Goldman Sachs
25
Goldman Sachs
New York
$549K -$685K -41,986 -49%